Leukotrap – Cp2d Solution
Loading...Leukotrap – Cp2d Solution Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Failure to achieve and maintain a closed system during processing would result in a product that must be transfused within 24 hours.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Whole blood; for use in blood collection.
History
There is currently no drug history available for this drug.
Other Information
For collection of blood and preparation of red blood cells, plasma and platelets with pre-storage leukocyte reduction.
Instruction for Use for Systems Containing a Y Sampling Site (YSS) or Sample Diversion Pouch (with or without a pre-attached SampLok™ Vacuum Tube Holder).
Refer to unit foil package label for specific product description being used.
Sterile, non-pyrogenic fluid path. Sterilized by steam.
Rx only.
IllustrationCollection system with sample diversion pouch
123-93 Collection System with Sample Diversion Pouch
Sources
Leukotrap – Cp2d Solution Manufacturers
-
Haemonetics Manufacturing Inc
![Leukotrap – Cp2d Solution (Anticoagulant Citrate Phosphate Double Dextrose ) Solution Leukotrap – As-3 Solution (Additive Solution – 3) Solution [Haemonetics Manufacturing Inc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Leukotrap – Cp2d Solution | Haemonetics Manufacturing Inc
There is currently no dosage information available for this product. We apologize for any inconvenience.
Login To Your Free Account